Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC). Azenosertib is being evaluated as a monotherapy and in co...
Use this information to figure out if this company is an ideal customer for you.
212.433.3791
10275 Science Center Dr
San Diego, 92121
201 - 500 Employees
$5M - $20M
linkedin.com/company/zentalis-pharmaceuticals
Zentalis Pharmaceuticals's CEO is Sabrina Kolenovic
Zentalis Pharmaceuticals's CMO is Robert E Winkler
Zentalis Pharmaceuticals's HQ is located at 10275 Science Center Dr, San Diego
Zentalis Pharmaceuticals's phone number is 212.433.3791
Zentalis Pharmaceuticals's official website is zentalis.com
Zentalis Pharmaceuticals's revenue is $5M - $20M
Zentalis Pharmaceuticals has 201 - 500 employees
Zentalis Pharmaceuticals is in the industry of: Pharmaceuticals
